JOURNAL ARTICLE

IVF Pioneer Monash Slumps 30% After News of Baby Born From Embryo Mix-Up.

  • Published In: Bloomberg.com, 2025. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Gale, Jason 3 of 3

Abstract

Monash IVF Group Ltd. experienced a 30% drop in its stock value after revealing that an embryo mix-up led to the birth of a child at its Brisbane clinic. The company, known for pioneering IVF technology, attributed the incident to human error and is conducting an independent investigation. Despite the seriousness of the situation, Monash IVF does not anticipate a significant impact on its 2025 earnings and has taken steps to enhance clinic safeguards. This event follows a previous controversy involving faulty genetic screening tests, for which the company settled a class-action lawsuit. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2025/04, pN.PAG
  • Document Type:Article
  • Subject Area:Technology
  • Publication Date:2025
  • Accession Number:184449533
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.